A Study to Determine the Presence or Absence of Restless Legs Syndrome/Willis Ekbom Disease (RLS/WED) and Document Severity Level of Symptoms in Patients Undergoing Opioid Withdrawal in the Mayo Clinic Pain Rehabilitation Center.

Overview

About this study

The purpose of this study is to utilize validated questionnaires to determine the presence or absence of Restless Legs Syndrome/Willis Ekbom Disease (RLS/WED) and document severity level of symptoms in patients undergoing opioid withdrawal in the Mayo Clinic Pain Rehabilitation Center.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Consented adult patients taking daily opioids at the time of admission to the Pain Rehabilitation Center will be included
Consented adult patients here for opioid tapering therapy
Patients with or without pre-existing history of RLS/WED can be enrolled

Exclusion Criteria:

Research authorization not provided
Pediatric patients (<18 years of age) and patients who are unable to provide consent or have significant language barrier (limiting understanding of the questionnaire) will be excluded from the study

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Melissa Lipford, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Melissa Lipford, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials